PH19156A - Dihydrocyclosporin d in the treatment of multiple sclerosis - Google Patents

Dihydrocyclosporin d in the treatment of multiple sclerosis

Info

Publication number
PH19156A
PH19156A PH28447A PH28447A PH19156A PH 19156 A PH19156 A PH 19156A PH 28447 A PH28447 A PH 28447A PH 28447 A PH28447 A PH 28447A PH 19156 A PH19156 A PH 19156A
Authority
PH
Philippines
Prior art keywords
dihydrocyclosporin
treatment
multiple sclerosis
sclerosis
Prior art date
Application number
PH28447A
Other languages
English (en)
Inventor
Salvatore Cammisuli
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH19156A publication Critical patent/PH19156A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH28447A 1982-02-01 1983-01-28 Dihydrocyclosporin d in the treatment of multiple sclerosis PH19156A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202776 1982-02-01

Publications (1)

Publication Number Publication Date
PH19156A true PH19156A (en) 1986-01-15

Family

ID=10528015

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28447A PH19156A (en) 1982-02-01 1983-01-28 Dihydrocyclosporin d in the treatment of multiple sclerosis

Country Status (5)

Country Link
JP (1) JPS58134031A (it)
AU (1) AU558155B2 (it)
BE (1) BE895724A (it)
IT (1) IT1197556B (it)
PH (1) PH19156A (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
DE3580717D1 (de) * 1984-08-02 1991-01-10 Sandoz Ag Pharmazeutische anwendung von (nva)2-cyclosporine.
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
HK1004520A1 (en) 1992-05-13 1998-11-27 Novartis Ag Ophthalmic compositions containing a cyclosporin
PT589843E (pt) * 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
SK285019B6 (sk) 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
IN188719B (it) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US8394763B2 (en) 2007-09-26 2013-03-12 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies

Also Published As

Publication number Publication date
IT1197556B (it) 1988-12-06
AU1085183A (en) 1983-08-11
AU558155B2 (en) 1987-01-22
IT8347644A0 (it) 1983-02-01
BE895724A (fr) 1983-07-28
JPS58134031A (ja) 1983-08-10

Similar Documents

Publication Publication Date Title
GB2122498B (en) Massager
DE3377263D1 (en) Skin treatment composition
PH19156A (en) Dihydrocyclosporin d in the treatment of multiple sclerosis
DE3378116D1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
GB8333890D0 (en) Metal treatment
JPS57171767A (en) Sizining treatment
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
GB2114021B (en) Baths
CA49536S (en) Bathtub
EG16991A (en) Therapeutic agents
GB2127261B (en) A process of sea-ranching salmon and the like
ZA837697B (en) Improvements in or relating to the treatment of multi-phase systems
GB2128192B (en) Naphthalenecarboxamides their production and use
ZA83662B (en) Skin treatment composition
GB8318580D0 (en) Therapeutic agent
GB2147008B (en) Surface treatment
CA51152S (en) Bathtub
ZA836848B (en) Therapeutic agents
GB2077265B (en) N-trifluoroacetyladriamycin-14-o-hemiglutarate and hemiadipate and therapeutic compositions containing the same
DE3367919D1 (en) Furochromones and furobenzopyrans
PT76807B (en) Phosphoramidothionate and their production and use
CA49742S (en) Treatment chair
GB8323354D0 (en) Ranging
ZA834855B (en) Treatment
ZA837183B (en) The treatment of ferromanganese